Home JD Pharmacy Celebrates 8th Anniversary: Driving High-Quality Growth and Digital Transformation in the Pharmaceutical Industry

JD Pharmacy Celebrates 8th Anniversary: Driving High-Quality Growth and Digital Transformation in the Pharmaceutical Industry

May 16, 2024 19:34 CST Updated 19:34
JD Health

Internet Medical and Health Service Platform Provider

On May 15, JD Pharmacy’s 8th Anniversary Partner Conference was held in Beijing. Over the past eight years since its launch, JD Pharmacy has leveraged JD Health’s position as the “primary online portal for health consumption” to build “new quality productive forces” characterized by high technology, high efficiency, and high quality. It has continuously unlocked the value of being the “go-to platform for medication purchases,” while working closely with its extensive partner network to accelerate the digital transformation of the pharmaceutical industry and drive new growth through new quality productive forces.

 

The CEO of JD Health stated that JD Pharmacy, as the core stronghold of JD Health in the pharmaceutical retail sector, has provided users with superior products and services while opening up broader growth opportunities for industry partners. Looking ahead, JD Pharmacy aims to establish long-term, in-depth, and comprehensive collaborations with its partners to explore more diversified development pathways. Together, they seek to unleash vitality and drive systemic upgrades within the pharmaceutical retail industry, thereby building new competitive advantages and sustaining momentum for the high-quality development of the pharmaceutical industry.

 

Providing users with a service experience that is “more comprehensive, faster, better, and more cost-effective” to continuously enhance user stickiness


With rising health awareness among residents, the user base for internet healthcare has continued to grow, while the market size of pharmaceutical e-commerce and retail drug sales has expanded steadily. JD Pharmacy has built an integrated online-to-offline retail system, delivering a service experience that is “more comprehensive, faster, better, and more cost-effective.”

 

A richer product supply, faster fulfillment speed, better service guarantees, and more affordable prices are key to ensuring a high-quality pharmaceutical consumption experience. In 2023, the number of merchants, stores, and products selling pharmaceuticals on the JD platform all doubled, achieving full coverage of all online-listable drug varieties. In 2023 alone, JD Pharmacy sold 1 billion boxes of medication. Regarding delivery experience, leveraging its nationwide network of 24 pharmaceutical warehouses, JD Pharmacy achieved same-day or next-day delivery for over 90% of orders, with cold-chain logistics covering more than 300 cities across China. In terms of medication experience, JD Pharmacy’s pharmacists provide professional and convenient pharmaceutical services to users 24/7. To date, they have delivered over 20 million professional pharmaceutical consultations, achieving a 99% customer satisfaction rate and an industry-leading Net Promoter Score (NPS). Additionally, JD Pharmacy has helped users reduce medication costs through various price-reduction initiatives such as the “Ten Billion Subsidy” program.

 

This series of achievements not only demonstrates users’ strong recognition and trust in JD Pharmacy, but also underscores JD Pharmacy’s robust capabilities as the “primary destination for purchasing medications.”

 

Innovative Collaboration Models Empower Pharmaceutical Partners to Achieve New-Quality Growth


In the face of evolving market trends, JD Pharmacy has rapidly expanded its drug portfolio and enhanced product quality and service standards through deep collaboration with pharmaceutical companies. In turn, these pharmaceutical partners have effectively broadened their distribution channels and increased their market share by leveraging JD Pharmacy’s robust online-to-offline (O2O) integrated retail system. Furthermore, JD Pharmacy actively empowers its pharmaceutical partners through digital marketing, helping them achieve high-quality, innovative growth.

 

The launch of new drugs is not only a concentrated demonstration of pharmaceutical companies’ R&D and innovation achievements, but also a significant indicator of their competitiveness and market leadership. In 2023, more than 100 innovative drugs, including Pfizer’s Litfulo for alopecia areata, AstraZeneca’s Forxiga for diabetes, and Teva Pharmaceuticals’ deutetrabenazine for Huntington’s disease, were first launched online at JD Pharmacy. This further solidified JD Pharmacy’s position as the premier platform for the nationwide online debut of new and specialized medications. By providing a comprehensive, full-cycle solution for the online launch of new drugs, JD Pharmacy helps pharmaceutical companies shorten the time required to reach the market and accelerate rapid sales growth.


Currently, AI technologies represented by large language models are driving profound transformations across various industries. Following the release of the “Jingyi Qianxun” medical large model in 2023, JD Pharmacy applied its data capabilities and large model technologies to the entire pharmaceutical transaction lifecycle. It built digital marketing capabilities from the ground up, precisely connecting the dual centers of patients and healthcare providers. This enables pharmaceutical companies to gain precise market insights and user behavior analysis, facilitating efficient engagement across the “medical–pharmaceutical–service” ecosystem and helping brands achieve comprehensive optimization from product positioning to marketing strategies.

 

In the future, JD Pharmacy will further open up its large language model capabilities, including big data on the omni-channel circulation of pharmaceuticals and JD Health’s AKSO Intelligent Health Data Model from the JD Health Data Research Institute, to help pharmaceutical enterprise partners uncover more business opportunities. By deeply integrating cutting-edge technologies such as cloud computing, big data, and artificial intelligence, JD Pharmacy has not only reshaped the traditional model of pharmaceutical distribution but also continues to lead the industry’s digital and intelligent transformation.

 

Building a Digital Industry Ecosystem to Leverage the Synergistic Value of Upstream and Downstream Players in the Industrial Chain


An open, shared, and complementary innovation ecosystem is the core driver propelling the development of the pharmaceutical industry. JD Pharmacy has long been committed to leveraging third-party resource integration to jointly unlock the potential of time-honored brands and emerging national pharmaceutical brands, working hand in hand to provide users with a more comprehensive selection of medications at lower prices and higher quality.

 

Data shows that in the past three years, an increasing number of time-honored brands and emerging national pharmaceutical brands have begun to leverage JD Health for their digital transformation. Building on this momentum, JD Pharmacy aims to unlock greater incremental growth through deeper collaboration with numerous partners who share aligned values and complementary capabilities. At the conference, JD Pharmacy announced the joint creation of the “Time-Honored Brand Ecosystem Partner Zone” in partnership with the Time-Honored Brand Enterprise Development Professional Committee of the China Association of Traditional Chinese Medicine. Leveraging JD Health’s inherent strengths, this zone will collaborate with brands to enhance conversion efficiency through effective content-driven engagement and optimized conversion pathways. Representatives from brands such as Tongrentang, Dong-E-E-Jiao, Foci Pharmaceutical, Guangyuyuan, Hu Qing Yu Tang, and Yunnan Baiyao attended the signing ceremony marking the launch of the zone.


image.png

“Time-Honored Brand Ecosystem Partner Zone” Launch and Signing Ceremony


Family health has always been a key focus of public concern. An increasing number of users have become accustomed to purchasing common medications through e-commerce platforms for emergency preparedness. In response to this demand, JD Pharmacy, in collaboration with dozens of renowned pharmaceutical brands including China Resources Sanjiu, Baiyunshan, Sino-American SmithKline, Yangtze River Pharmaceutical Group, and HEC Pharm, launched the “Household Essentials, Peace of Mind Always” family health protection initiative at this conference. The project aims to provide more users with a convenient, one-stop medication shopping experience, covering a wide range of household staple medicines for conditions such as colds and fever, bruises and sprains, abdominal pain and diarrhea, eye strain, skin health, and seasonal allergies.


image.png

Launch Event of the Family Health Guardian Project


The event also saw the presentation of awards including the Annual Partner Award, JD Pharmacy Trusted Brand Award, Emerging Brand Award, Social Responsibility Award, Innovative Marketing Award, and Outstanding Supplier Award. These honors recognized partner brands and enterprises that demonstrated exceptional performance, outstanding innovation, and significant social contributions throughout their collaboration with JD Pharmacy. Through these awards, JD Pharmacy not only highlighted its recognition and support for its partners’ achievements but also further articulated its vision of building a healthy and thriving pharmaceutical e-commerce ecosystem.


image.png

Award Ceremony


The 8th Anniversary Partner Conference of JD Pharmacy not only summarizes the experiences of the past eight years but also looks forward to future collaboration and innovation. By continuously deepening technological applications, optimizing user experience, strengthening collaborative partnerships with pharmaceutical companies, and actively fulfilling social responsibilities, JD Pharmacy is gradually building a smart, symbiotic, and sustainable health ecosystem. In the future, JD Pharmacy will continue to work hand in hand with all partners to jointly explore new-quality growth in the pharmaceutical and healthcare sector, accelerating the implementation of the Healthy China Initiative.